Class II recall: Baxter Healthcare Corporation: Clindamycin Injection USP in 5% Dextrose, 600 mg per 50 mL (12 mg/mL) in GALAXY

The FDA has classified as Class II a recall by Baxter Healthcare Corporation of Clindamycin Injection USP in 5% Dextrose, 600 mg per 50 mL (12 mg/mL), supplied in GALAXY 50 mL Single Dose Containers (NDC 0338-3612-50). The recall notice cites current good manufacturing practice (CGMP) deviations as the reason for the action.

Most relevant for: patients receiving clindamycin injection for bacterial infections via intravenous infusion

Summary written by an AI model from the source text and dated by the source's publication date. Check the original before acting on it. How MedFollow selects and summarizes updates.

Informational only. Not medical advice. Not a substitute for clinical judgment. Always consult current guidelines and your own clinical judgment.